Bruker Q1 revenue rises 2.7% to $823.4 million, but non-GAAP EPS falls to $0.31
Bruker reported first quarter 2026 revenue of $823.4 million, up 2.7% from a year earlier, but organic revenue fell 4.4%. Non-GAAP diluted EPS was $0.31 versus $0.47 a year earlier, and GAAP diluted EPS was $0.02 versus $0.11, so profit declined even as sales rose. The company reconfirmed its prior fiscal 2026 guidance for revenue of $3.57 to $3.60 billion and non-GAAP EPS of $2.10 to $2.15.
Key points
- Q1 2026 revenue $823.4 million, up 2.7% year over year; organic revenue down 4.4%
- Non-GAAP diluted EPS $0.31 vs. $0.47 in Q1 2025; GAAP diluted EPS $0.02 vs. $0.11
- Non-GAAP operating margin 10.2% vs. 12.7% a year earlier
- FY2026 guidance reconfirmed: revenue $3.57 to $3.60 billion and non-GAAP EPS $2.10 to $2.15
The filing
Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.